Eisai to Divest Rights for Zonegran in Europe and Other Regions to Advanz Pharma
TOKYO, Jun 15, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for the antiepileptic agent […]